Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
McKinsey
Express Scripts
Johnson and Johnson
Dow

Last Updated: August 19, 2022

STERITALC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Steritalc patents expire, and when can generic versions of Steritalc launch?

Steritalc is a drug marketed by Novatech Sa and is included in one NDA.

The generic ingredient in STERITALC is talc. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the talc profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Steritalc

A generic version of STERITALC was approved as talc by SCIARRA LABS on December 15th, 2003.

  Try it Free

Summary for STERITALC
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in STERITALC?STERITALC excipients list
DailyMed Link:STERITALC at DailyMed
Drug patent expirations by year for STERITALC

US Patents and Regulatory Information for STERITALC

STERITALC is protected by zero US patents and two FDA Regulatory Exclusivities.

FDA Regulatory Exclusivity protecting STERITALC

TO DECREASE THE RECURRENCE OF MALIGNANT PLEURAL EFFUSIONS IN SYMPTOMATIC PATIENTS FOLLOWING MAXIMAL DRAINAGE OF THE PLEURAL EFFUSION
Exclusivity Expiration: See Plans and Pricing

TO DECREASE THE RECURRENCE OF PNEUMOTHORAX IN ADULTS
Exclusivity Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novatech Sa STERITALC talc POWDER;INTRAPLEURAL 205555-001 May 1, 2017 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Novatech Sa STERITALC talc POWDER;INTRAPLEURAL 205555-002 May 1, 2017 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Novatech Sa STERITALC talc POWDER;INTRAPLEURAL 205555-003 May 1, 2017 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Baxter
McKesson
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.